Matinas BioPharma Holdings, Inc. (MTNB) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.21M |
| Enterprise Value | 562,839 |
| P/E Ratio | -0.34 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.46 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.91 |
| Return On Equity | -2.04 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -456,000 |
| EBITDA | -9.89M |
| Net Income | -10.35M |
| Diluted EPS | -2 |
| Total Cash | 2.45M |
| Total Cash/Share | 0.38 |
| Total Debt | 1.19M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1.32 |
| Book Value Per Share | 0.47 |
| 52-Week Change | -28.44 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.48 |
| Moving Average 50 Days | 0.66 |
| Moving Average 200 Days | 0.91 |
| Average Volume | 151,991 |
| Shares Outstanding | 5.55M |
| % Held by Institutions | 6.47 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | September 03, 2024 |